Cetera Investment Advisers’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$525K Buy
21,430
+2,863
+15% +$67.8K ﹤0.01% 3465
2025
Q4
$461K Buy
+18,567
New +$493K ﹤0.01% 3507

Other funds holding ASTH

Cetera Investment Advisers's ASTH Position: Q1 2026 in Review

Cetera Investment Advisers increased its Astrana Health (ASTH) stake by 15% in Q1 2026, buying an estimated $67.8K and bringing the position to 21,430 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #3465.

Cetera Investment Advisers first reported a position in ASTH in Q4 2025 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Cetera Investment Advisers held 21,430 shares of Astrana Health worth $525K as of Q1 2026.
  • Cetera Investment Advisers bought 2,863 Astrana Health shares in Q1 2026, an estimated $67.8K.
  • Astrana Health made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3465 holding.
  • Cetera Investment Advisers first reported a position in Astrana Health in Q4 2025 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.